+

WO2001096350A3 - Haplotypes du gene grm3 - Google Patents

Haplotypes du gene grm3 Download PDF

Info

Publication number
WO2001096350A3
WO2001096350A3 PCT/US2001/019447 US0119447W WO0196350A3 WO 2001096350 A3 WO2001096350 A3 WO 2001096350A3 US 0119447 W US0119447 W US 0119447W WO 0196350 A3 WO0196350 A3 WO 0196350A3
Authority
WO
WIPO (PCT)
Prior art keywords
grm3
gene
haplotypes
disclosed
haplotyping
Prior art date
Application number
PCT/US2001/019447
Other languages
English (en)
Other versions
WO2001096350A2 (fr
Inventor
Kevin Finkel
Beena Koshy
Debra A Tanguay
Original Assignee
Genaissance Pharmaceuticals
Kevin Finkel
Beena Koshy
Debra A Tanguay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Kevin Finkel, Beena Koshy, Debra A Tanguay filed Critical Genaissance Pharmaceuticals
Priority to AU2001271327A priority Critical patent/AU2001271327A1/en
Publication of WO2001096350A2 publication Critical patent/WO2001096350A2/fr
Publication of WO2001096350A3 publication Critical patent/WO2001096350A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention se rapporte à de nouveaux variants génétiques du gène métabotrope, récepteur du glutamate (GRM3). L'invention se rapporte à divers génotypes, haplotypes et paires d'haplotypes associés au germe GRM3 et existant dans la population des Etats-Unis. L'invention se rapporte à des compositions et à des procédés permettant l'haplotypage et/ou le génotypage du gène GRM3 chez un individu. Elle se rapporte également à des polynucléotides définis par les haplotypes décrits ci-dessus.
PCT/US2001/019447 2000-06-16 2001-06-18 Haplotypes du gene grm3 WO2001096350A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001271327A AU2001271327A1 (en) 2000-06-16 2001-06-18 Haplotypes of the grm3 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21232800P 2000-06-16 2000-06-16
US60/212,328 2000-06-16

Publications (2)

Publication Number Publication Date
WO2001096350A2 WO2001096350A2 (fr) 2001-12-20
WO2001096350A3 true WO2001096350A3 (fr) 2002-10-10

Family

ID=22790535

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/019447 WO2001096350A2 (fr) 2000-06-16 2001-06-18 Haplotypes du gene grm3

Country Status (2)

Country Link
AU (1) AU2001271327A1 (fr)
WO (1) WO2001096350A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8795964B2 (en) 2010-09-23 2014-08-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services GRM3 mutations and use thereof for the diagnosis and treatment of melanoma

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
AMERICAN JOURNAL OF MEDICAL GENETICS, vol. 14, no. 1, 8 January 2002 (2002-01-08), pages 46 - 50 *
DATABASE MEDLINE [online] BORT ET AL.: "Metabotropic glutamate receptor 3 gene variation is not associated with schizophrenia or bipolar effective disorder in the German population", XP002952555, Database accession no. 2002118223 *

Also Published As

Publication number Publication date
WO2001096350A2 (fr) 2001-12-20
AU2001271327A1 (en) 2001-12-24

Similar Documents

Publication Publication Date Title
WO2002006294A3 (fr) Haplotypes du gene mmp13
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2002026764A3 (fr) Haplotypes du gene ccr6
WO2001096350A3 (fr) Haplotypes du gene grm3
WO2002038587A3 (fr) Haplotypes du gene grm8
WO2002010454A3 (fr) Haplotypes du gene alas2? ¿
WO2002006446A3 (fr) Haplotypes du gene edg6
WO2001077363A3 (fr) Haplotypes du gene impdh2
WO2002016399A3 (fr) Haplotypes du gene tacr1
WO2002020556A3 (fr) Haplotypes du gene gpr68
WO2002050098A3 (fr) Haplotypes du gene du recepteur de la prolactine (prlr)
WO2001087904A3 (fr) Haplotypes du gene gpr4
WO2001090128A3 (fr) Haplotypes du gene gpr3
WO2002032928A3 (fr) Haplotypes du gene hrh1
WO2001087909A3 (fr) Haplotypes du gene aanat
WO2002032924A3 (fr) Haplotypes du gene chrm5
WO2002040502A3 (fr) Haplotypes du gene de la lipase hormono-sensible
WO2002026766A3 (fr) Haplotypes du gene sstr4
WO2001090118A3 (fr) Haplotypes du gene edn2
WO2001090124A3 (fr) Haplotypes du gene gpr31
WO2002012499A3 (fr) Haplotypes du gene ntf3
WO2001087908A3 (fr) Haplotypes du gene ccr3
WO2002036610A3 (fr) Haplotypes du gene adora3
WO2002036609A3 (fr) Haplotypes du gene chrm4
WO2002012561A3 (fr) Haplotypes du gene or1g1

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WPC Withdrawal of priority claims after completion of the technical preparations for international publication

Ref country code: WO

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载